Digitale Landesbibliothek Berlin Logo

Prevalence of rheumatoid arthritis in China: Variations and trends from the global burden of disease study 2021 / Cheng, Yan (CC BY)

Access restriction

There is no access restriction for this record.

Copyright

CC BY: Attribution 4.0 International. You can find more information here.

Bibliographic data

fullscreen : Prevalence of rheumatoid arthritis in China: Variations and trends from the global burden of disease study 2021 / Cheng, Yan (CC BY)

Access restriction

There is no access restriction for this record.

Copyright

CC BY: Attribution 4.0 International. You can find more information here.

Files

External resources

Unlock

Prevalence of rheumatoid arthritis in China: Variations and trends from the global burden of disease study 2021 / Cheng, Yan (CC BY)

You can request access to this file here. You will receive an e-mail confirming that we have successfully received your request.

Prevalence of rheumatoid arthritis in China: Variations and trends from the global burden of disease study 2021 / Cheng, Yan (CC BY)

The access to this file is restricted.

What is the fourth digit in the number series 987654321?:

I hereby confirm the use of my personal data within the context of the enquiry made.

Periodical

Title:
Rheumatology and immunology research
Publication:
Berlin: Walter de Gruyter
Note:
Gesehen am 22. März 2022
Archivierung/Langzeitarchivierung gewährleistet
Scope:
Online-Ressource
ISSN:
2719-4523
ZDB-ID:
3113848-2 ZDB
VÖBB-Katalog:
35423539
Keywords:
Zeitschrift
Classification:
Medizin
Collection:
Medizin
Copyright:
Rights reserved
Accessibility:
Free Access
Title:
Rheumatology and immunology research
Publication:
Berlin: Walter de Gruyter
Note:
Gesehen am 22. März 2022
Archivierung/Langzeitarchivierung gewährleistet
Scope:
Online-Ressource
ISSN:
2719-4523
ZDB-ID:
3113848-2 ZDB
VÖBB-Katalog:
35423539
Keywords:
Zeitschrift
Classification:
Medizin
Collection:
Medizin
Copyright:
Rights reserved
Accessibility:
Free Access

Article

Author:
Cheng, Yan
Shao, Tihong
Chen, Xingdong
Title:
Prevalence of rheumatoid arthritis in China: Variations and trends from the global burden of disease study 2021
Publication:
Berlin: Walter de Gruyter, 2025
Language:
English
Information:
Background and Objectives: The latest prevalence data for rheumatoid arthritis (RA) is essential for effective disease control and management. Although numerous studies examine the global burden of RA, recent data specific to China has been lacking. The aim of this study is to evaluate the variations of RA burden in mainland China from 1990 to 2021 utilizing data from the Global Burden of Diseases, Injuries, and Risk Factors (GBD) study 2021. Methods: We conducted a retrospective analysis of RA burden in China based on the GBD 2021 study. We collected data on RA prevalence, incidence, and disability adjusted life years in China from 1990 to 2021, then calculated the estimated annual percentage change (EAPC) to summarize the overall trends. Results: In 2021, the total numbers of prevalent cases, incident cases, and disability-adjusted life years (DALYs) for RA in China were 4,755,500, 247,300, and 833,800, respectively; From 1990 to 2021, the rates of incidence, prevalence, and DALYs of RA showed an increasing trend, with EAPCs of 0.61, 0.59, and 0.17, respectively. Throughout this period, the RA burden was notably higher in females than in males. In 2021, RA incidence rates among individuals aged 15–44, 45–59, and 60–85+ followed an approximate 1∶1∶1 ratio. Projections using the Bayesian Age-Period-Cohort (BAPC) model indicated that by 2045, compared to 2021, the total incident cases, prevalent cases, and DALYs of RA in China are expected to increase by 15.7%, 13.2%, and 4.2%, respectively. Conclusion: Over the past 32 years, the RA burden in China had continued to increase, and is expected to rise substantially over the next decade. Therefore, it is necessary to strengthen the prevention and management of RA, with priority given to the female population and young patients.
Scope:
Online-Ressource
Note:
Open Access
Archivierung/Langzeitarchivierung gewährleistet
Keywords:
rheumatoid arthritis ; prevalence ; incidence ; disability-adjusted life years ; GBD 2021
Classification:
Medizin
Sonstiges
URN:
urn:nbn:de:101:1-2507020621090.981162567303
Collection:
Medizin
Sonstiges
Copyright:
CC BY
Accessibility:
Free Access
Author:
Cheng, Yan
Shao, Tihong
Chen, Xingdong
Title:
Prevalence of rheumatoid arthritis in China: Variations and trends from the global burden of disease study 2021
Publication:
Berlin: Walter de Gruyter, 2025
Language:
English
Information:
Background and Objectives: The latest prevalence data for rheumatoid arthritis (RA) is essential for effective disease control and management. Although numerous studies examine the global burden of RA, recent data specific to China has been lacking. The aim of this study is to evaluate the variations of RA burden in mainland China from 1990 to 2021 utilizing data from the Global Burden of Diseases, Injuries, and Risk Factors (GBD) study 2021. Methods: We conducted a retrospective analysis of RA burden in China based on the GBD 2021 study. We collected data on RA prevalence, incidence, and disability adjusted life years in China from 1990 to 2021, then calculated the estimated annual percentage change (EAPC) to summarize the overall trends. Results: In 2021, the total numbers of prevalent cases, incident cases, and disability-adjusted life years (DALYs) for RA in China were 4,755,500, 247,300, and 833,800, respectively; From 1990 to 2021, the rates of incidence, prevalence, and DALYs of RA showed an increasing trend, with EAPCs of 0.61, 0.59, and 0.17, respectively. Throughout this period, the RA burden was notably higher in females than in males. In 2021, RA incidence rates among individuals aged 15–44, 45–59, and 60–85+ followed an approximate 1∶1∶1 ratio. Projections using the Bayesian Age-Period-Cohort (BAPC) model indicated that by 2045, compared to 2021, the total incident cases, prevalent cases, and DALYs of RA in China are expected to increase by 15.7%, 13.2%, and 4.2%, respectively. Conclusion: Over the past 32 years, the RA burden in China had continued to increase, and is expected to rise substantially over the next decade. Therefore, it is necessary to strengthen the prevention and management of RA, with priority given to the female population and young patients.
Scope:
Online-Ressource
Note:
Open Access
Archivierung/Langzeitarchivierung gewährleistet
Keywords:
rheumatoid arthritis ; prevalence ; incidence ; disability-adjusted life years ; GBD 2021
Classification:
Medizin
Sonstiges
URN:
urn:nbn:de:101:1-2507020621090.981162567303
Collection:
Medizin
Sonstiges
Copyright:
CC BY
Accessibility:
Free Access

Contents

Table of contents

  • Rheumatology and immunology research (Rights reserved)
  • Dual-tracer PET/CT imaging with 68 Ga-DOTATATE and Al 18 F-NOTA-FAPI for dynamic evaluation of myocardial inflammation and fibrosis in antimitochondrial antibody-positive myositis / Qian, Junyan (CC BY)
  • Comment on: “Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort study” / Bakay, Umut (CC BY)
  • Nursing insights into CAR T-cell therapy for systemic lupus erythematosus: Highlights of a standardized nursing system for CAR T-cell therapy / Yang, Yujie (CC BY)
  • Giant cell arteritis initially presents as pulmonary embolism / Xu, Xinyuan (CC BY)
  • Efficacy and safety of Xeligekimab (GR1501) in the treatment of axial Spondyloarthritis: Results from a Phase II clinical trial / Zeng, Xiaofeng (CC BY)
  • Community-based epidemiological study on the prevalence and health status of Spondyloarthritis in residents of Wuyuan County, China, 2023 / Yu, Shichao (CC BY)
  • Hospital-based first diagnoses of systemic sclerosis: Defining initial clinical presentations and diagnostic pathways / Luengthanapol, Teerapat (CC BY)
  • Neuropsychiatric systemic lupus erythematosus subtypes identified by unsupervised clustering: A single-center cohort study / Fang, Weiting (CC BY)
  • Diffuse alveolar hemorrhage in rheumatic diseases: Clinical features, diagnosis, and management / Dutta, Nilanjana (CC BY)
  • Insights into familial Mediterranean fever: Chronic disease correlations with arthralgia and current health status of patients with familial Mediterranean fever in Jordan / Al-Hawamdeh, Mai I. (CC BY)
  • Insights into the clinical and immunological significance of anti-α-fodrin antibodies in systemic lupus erythematosus / Espinosa-Bautista, Fernanda (CC BY)
  • Predicting response to infliximab and interferon-α in Behçet’s syndrome: An exploratory analysis from the BIO-BEHÇET’S randomized controlled trial / Moots, Robert J. (CC BY)
  • Efficacy and safety of 2% isosorbide cream in systemic sclerosis patients with digital ulcers and Raynaud’s phenomenon / Namvijit, Suwassa (CC BY)
  • Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort study / Bai, Wei (CC BY)
  • Medusas petrifying gaze: Severe, diffused and refractory calcinosis from a patient with ACA-negative CREST syndrome / Xu, Lili (CC BY)
  • Circ_0088200 acts as a sponge for miR-127-5p to promote the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes / Cai, Yujie (CC BY)
  • ˜Theœ causal relationship between obstructive sleep apnea and rheumatic disease: A bidirectional Mendelian randomization study / Chen, Ming (CC BY)
  • Anti-CD20 therapy in lupus nephritis: A revisit / Mok, Chi Chiu (CC BY)
  • Tadalafil plus endothelin receptor antagonists in connective tissue disease-associated pulmonary arterial hypertension: A multicenter study on exercise capacity and cardiac outcomes / Wu, Qianwen (CC BY)
  • Nitazoxanide alleviates CFA-induced rheumatoid arthritis in Wistar rats by modulating the STAT-3 and NF-κB pathways / Prajapati, Pradyuman (CC BY)
  • Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treated / Micheli, Giulia (CC BY)
  • Antiphospholipid antibody-associated cystic lesion of the pancreatic head with concurrent acute pancreatitis / Hong, Junxian (CC BY)
  • Angular assessment of joints in juvenile idiopathic arthritis / Banerjee, Sudip (CC BY)
  • Prevalence of rheumatoid arthritis in China: Variations and trends from the global burden of disease study 2021 / Cheng, Yan (CC BY)
  • Investigating the role of tripartite motif containing-21 and interleukin-6 in pro-Inflammatory symptom-associated heterogeneity within primary Sjögren’s syndrome / Scott, Lauren R. (CC BY)
  • 2025 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus / Zhao, Jiuliang (CC BY)
  • How will we treat systemic lupus erythematosus in the next 5 years? / Zhao, Jiuliang (CC BY)
  • Proceedings of cell-free noncoding RNA biomarker studies in liquid biopsy / Zhu, Yumin (CC BY)
  • Reevaluating risk assessment in connective tissue disease-associated pulmonary arterial hypertension: The prognostic superiority of stroke volume index / Cai, Qingqing (CC BY)
  • ˜Theœ storm inside: Abdominal and urinary complications in lupus / Zheng, Shaoyu (CC BY)
  • Prevalence and characteristics of concomitant septic and crystal-induced arthritis: A hospital database and literature review / Duangkum, Kittikorn (CC BY)
  • Association of ficolin single nucleotide polymorphism with systemic lupus erythematosus in the Chinese Han Population / Yin, Feng (CC BY)
  • Association of HLA-B and HLA-DR gene polymorphisms with rheumatoid arthritis: A cross-sectional study in Yunnan Chinese Han population / Dong, Jing (CC BY)
  • Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis: 2024 update / Tian, Xinping (CC BY)
  • ˜Theœ potential for biosimilars to address unmet clinical need — Is the developed world missing out? / Yeoh, Whei Chuern (CC BY)
  • Immunomodulatory effects of novel nano micelle based curcumin in rheumatoid arthritis patients: A double blind randomized clinical trial / Khamar, Faezeh (CC BY)
  • “Bouncing temporomandibular joint”: Multiple temporomandibular lesions in a patient with rheumatoid arthritis / Li, Jun (CC BY)
  • Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases / Huang, Hongpeng (CC BY)
  • Enhancing standardized diagnosis and treatment to improve the prognosis of patients with rheumatoid arthritis in China / Jiang, Nan (CC BY)
  • McArdle’s disease presents with multiple large vessel lesions / Guo, Shuning (CC BY)
  • 14-3-3 Eta protein as a novel biomarker in early detection of uveitis in Egyptian juvenile idiopathic arthritis and rheumatoid arthritis patients: Diagnostic and prognostic value / Saif, Dalia Salah (CC BY)
  • Hemorrhage or thrombosis? Adrenal involvements in a patient with antiphospholipid syndrome / Liu, Lingshan (CC BY)
  • Spondyloarthritis recognition for primary care: A simplified diagnostic and referral pathway for general physicians / Khan, Anum (CC BY)
  • ˜Theœ mystery of the blue toe / Wang, Jing (CC BY)
  • Development and validation of the manual disease activity score (MDAS) for rheumatoid arthritis / Salim, Babur (CC BY)
  • Unveiling the dual nature of late-onset systemic lupus erythematosus: A cross-sectional study / Lu, Fengyun (CC BY)
  • CD209 gene polymorphism and its clinical correlation with susceptibility to rheumatoid arthritis among Egyptian patients: A case-control study / Elnagar, Rasha Mokhtar (CC BY)
  • Features of IgG4-related sclerosing mesenteritis: A Chinese cohort study and literature review / Zhang, Jialei (CC BY)
  • Crystal deposition disease of the shoulder at uncommon sites: Diagnostic challenges and nomenclature issues in the absence of synovial fluid analysis / Nigro, Angelo (CC BY)
  • Clinical implications of seropositive and seronegative autoantibody status in rheumatoid arthritis patients: A comparative multicentre observational study / Hammam, Nevin (CC BY)
  • Outcomes of myocarditis in systemic sclerosis: A 3-year follow-up / Mahakkanukrauh, Ajanee (CC BY)
  • ˜Theœ emerging role of cardiovascular magnetic resonance in the evaluation of cardiac involvement in systemic sclerosis / Mavrogeni, Sophie I. (CC BY)
  • ˜Theœ effect of anti-TNF drugs on the intestinal microbiota in patients with spondyloarthritis, rheumatoid arthritis, and inflammatory bowel diseases / Ciccia, Francesco (CC BY)
  • Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art! / Colic, Jelena (CC BY)
  • Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigation / Matucci-Cerinic, Marco (CC BY)
  • Therapeutic strategies for primary heart involvement in systemic sclerosis / Batani, Veronica (CC BY)
  • Heart in a stone house: Systemic sclerosis with pericardial calcinosis / Li, Zhi (Rights reserved)
  • Blau syndrome mimics Takayasu’s arteritis: Report of 2 cases with literature review / Ma, Xin (CC BY)
  • ˜Theœ vanishing touch: Unveiling the tuft erosion in scleroderma / Jiang, Hui (CC BY)
  • Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions / Albu, Mihai Tudor (CC BY)
  • Cardiac magnetic resonance imaging in systemic sclerosis: Heart involvement in high-resolution / Fairley, Jessica L. (CC BY)
  • Chinese guideline for the diagnosis and treatment of Takayasu’s arteritis (2023) / Tian, Xinping (CC BY)
  • Twists and turns: The whirl sign in a patient with systemic sclerosis / Qiao, Lin (CC BY)
  • Systemic sclerosis-associated interstitial lung disease: How to manage in 2024? / Bautista-Sanchez, Rocio (CC BY)
  • What can patients tell us in Sjögren’s syndrome? / Berry, Joe (CC BY)
  • Amyopathic dermatomyositis may be on the spectrum of autoinflammatory disease: A clinical review / Sharmeen, Saika (CC BY)
  • Not all geriatric cachexia is cancer – The difficult lateonset rheumatoid arthritis / Correia, Ana Rubim (CC BY)
  • Functional status of Indian children with juvenile idiopathic arthritis / Datta, Debadyuti (CC BY)
  • Pathogenesis of interstitial lung disease in systemic sclerosis / Goldman, Nina (CC BY)
  • MIP-C: A new autoimmune rheumatic disease concomitant with the COVID-19 pandemic / Brion, Katja (CC BY)
  • Early diagnosis and standardized treatment are critical to improve the prognosis of patients with Takayasu’s arteritis / Tian, Xinping (CC BY)
  • Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study / Werakiat, Jakrapan (CC BY)
  • Biomarkers in the evaluation of cardiac involvement in systemic sclerosis / Masri, Mohamad Fadhli Bin (CC BY)
  • High resolution computed tomography in systemic sclerosis: From diagnosis to follow-up / Ledda, Roberta Eufrasia (CC BY)

E-Pflicht Kooperationsprojekt "NP Regional"

Diese Publikation wurde im Rahmen des Kooperationsprojekts "NP Regional" von der Deutschen Nationalbibliothek übernommen. Sie fällt unter die E-Pflicht (Elektronische Pflichtpublikationen in Berlin).

Downloads

Downloads

Full record

TOC

Image fragment

Link to the viewer page with highlighted frame Link to IIIF image fragment

Formats and links

Formats and links

The metadata is available in various formats. There are also links to external systems.

Formats

METS METS (entire work) MARC XML Dublin Core

Cite

Cite

The following citation links are available for the entire work or the page displayed:

Full record

This page

Citation recommendation

Please check the citation before using it.

Search results

Search results

2 / 9,295
Back to search results

Image manipulation tools

Tools not available

Share image region

Use the mouse to select the image area you want to share.
Please select which information should be copied to the clipboard by clicking on the link:
  • Link to the viewer page with highlighted frame
  • Link to IIIF image fragment

Contact

Have you found an error? Do you have any suggestions for making our service even better or any other questions about this page? Please write to us and we'll make sure we get back to you.

What is the fourth digit in the number series 987654321?:

I hereby confirm the use of my personal data within the context of the enquiry made.